MedPath

Comparison of Efficacy Permethrin topical Cream in Combination with Doxycycline Tablet with Ivermectin topical Cream in Combination with Doxycycline Tablet in Treatment of cutaneus disease Rosacea Patients

Phase 3
Conditions
Rosacea papulopustular disease.
Registration Number
IRCT20210729052010N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
40
Inclusion Criteria

Diagnosis of typical papulopustular rosacea according two dermatologists and performance biopsy if rosacea is suspected
No treatment with topical steroids or other topical treatment during 14 days before starting study
No treatment with any systemic drugs by known effect on inflammation responses during 30 days before starting study
No treatment with topical retinoids during 30 days ago or systemic retinoids during 180 days before starting study
No treatment by physical modality that effect on rosacea lesions during 30 days before starting study
Absence of other cutaneous diseases that interfere with assessment lesions related to rosacea
Absence of comedon, cyst and scar that benefit to diagnosis of acne vulgaris
Absence of pregnancy and breastfeeding

Exclusion Criteria

Less than 18 years
Male gender

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase or decrease number and severity after use Ivermectin 1% cream or permetrin 5% cream. Timepoint: 0,6 and 12 weeks after starting treatment. Method of measurement: Photography from lesions and remission of lesions.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath